My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
February 2012
Patient Care and Science
Drug Approvals, Recalls, Adverse Events Update

IDSA offers two email services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Content includes a range of topics, including new drug approvals and warnings. Recent alerts have included:

IDSA members can sign up for these services online. (You must be logged in to have access to this link. Once logged in, click on the “My Alerts” tab to subscribe to the alerts. To subscribe, check the appropriate boxes to receive CDC’s Health Alert Network (HAN) messages and/or alerts from FDA, and provide your email address and name where indicated.)

Is Your Facility Experiencing Antibiotic Shortages?

IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at schang@idsociety.org.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
CDC Guidance for Influenza Antivirals Remains Unchanged
Medicare Website Reports Hospital CLABSI Rates
ACIP Recommends Tdap for All Adults, Including Those 65 and Older
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
Medicare Physician Payment Cuts Delayed for 10 Months
Global ID
Interview Series: CDC’s Role in Global HIV and TB
Experts Highlight Role of Prevention Interventions in Global AIDS Fight
PEPFAR Takes Hit in Obama’s FY2013 Budget
Policy and Advocacy
Obama’s FY2013 Budget Mixed Bag for ID, HIV/AIDS
HHS Advisory Group Recommends Voluntary Measures to Boost HCW Influenza Vaccination
Your Colleagues
Check Out “My IDSA” for Latest Member News
Education & Resources
CDC Lyme Disease Webinar: CME Credit Available
Adolescent Vaccination Education Materials Available
Top Stories
From the President:
How Is Antimicrobial Resistance Affecting Your Patients?
IDSA Urges Congress, FDA to Boost Antibiotic R&D
IDWeek 2012 Now Accepting Abstract Submissions
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.